Newer diabetes drug drops heart failure risk by 34 percent, study says
Newer drugs for type 2 diabetes called SGLT2 inhibitors may also have a beneficial side effect for cardiovascular health, with a study showing they can reduce heart failure risk by 34 percent.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Health | Heart | Heart Failure | SGLT2 Inhibitors | Study